TARGET data identifier (The Therapeutically Applicable Research to Generate Effective Treatments )
2
0
Entering edit mode
7.0 years ago
Zhenyu Zhang ▴ 370

It seems the information about target data is not well organized here http://ocg.cancer.gov/programs/target, and the name "TARGET" make it even more difficult for me to search online.  

In particular, if I got a data like TARGET-52-PADYZI-10A-01D, what does it mean? I know PADYZI is a patient id, but how about 52? is it a tissue code? then what are -10A-01D? subsample id? Does any of this information contains experiment type? Thanks

TARGET • 2.3k views
ADD COMMENT
1
Entering edit mode
7.0 years ago
Zhenyu Zhang ▴ 370

Thanks. By comparing TCGA code and naming of TARGET data, your guess is right.

TARGET-52-PADYZI-10A-01D
  • 52 is the disease type
  • 10 is the sample type (normal blood, tumor, etc)
  • A is the vial
  • 01 is the portion
  • D means DNA

Hope this will help others who is also working on TARGET data. I just don't understand why TARGET don't have this info explicitly described somewhere.

ADD COMMENT
0
Entering edit mode

Thanks for clarifiying. I didnt know what "A" means.

ADD REPLY
0
Entering edit mode
7.0 years ago

I dont know about TARGET, however the notation reminds me of the "legacy sample id" naming scheme at TCGA, where

  • 10A is the sample type with 10="Blood derived Normal" or 01="Primary solid tumor" or 06="Metastatic" and so on
  • 01D ist the analyte code with D=DNA or R=RNA, T=Total RNA

Also see: https://tcga-data.nci.nih.gov/datareports/codeTablesReport.htm

I hope this helps a bit.

ADD COMMENT
0
Entering edit mode

I know 06="Metastatic", I don't know whether the metastatic sample is from the breast or not  when  the breast cancer sample type is 06.such as 06 means Metastatic, I don't know the cancer cell transferred before the surgery or after。what does Additional Metastatic mean?

ADD REPLY

Login before adding your answer.

Traffic: 1890 users visited in the last hour
Help About
FAQ
Access RSS
API
Stats

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.

Powered by the version 2.3.6